Average Co-Inventor Count = 3.21
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xspray Pharma Ab (9 from 17 patents)
2. Umecrine Cognition Ab (2 from 7 patents)
3. Xspray Microparticles Ab (1 from 16 patents)
12 patents:
1. 11833249 - Rapidly disintegrating solid oral dosage forms containing dasatinib
2. 11529351 - Fast dissolving pharmaceutical compositions
3. 11344500 - Rapidly disintegrating solid oral dosage forms containing dasatinib
4. 11123351 - Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime
5. 10894017 - Rapidly disintegrating solid oral dosage forms containing dasatinib
6. 10894018 - Rapidly disintegrating solid oral dosage forms containing dasatinib
7. 10874613 - Rapidly disintegrating solid oral dosage forms containing dasatinib
8. 10874614 - Rapidly disintegrating solid oral dosage forms containing dasatinib
9. 10869836 - Rapidly disintegrating solid oral dosage forms containing dasatinib
10. 10869837 - Rapidly disintegrating solid oral dosage forms containing dasatinib
11. 10799459 - Rapidly disintegrating solid oral dosage forms containing dasatinib
12. 10603326 - Pharmaceutical formulation of 3α-ethynyl-3β-hydroxyandrostan-17-one oxime